|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/395 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 39/39558 | (2013.01) | ||
| A61K 31/4162 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/2887 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3500299 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17841107.0 |
| Europos patento paraiškos padavimo data | 2017-08-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-06-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-12-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/098023 |
| Data | 2017-08-18 |
| (87) | Numeris | WO 2018/033135 |
| Data | 2018-02-22 |
| (30) | Numeris | Data | Šalis |
| PCT/CN2016/096082 | 2016-08-19 | WO |
| (72) |
HU, Nan , CN
WANG, Lai , CN
SONG, Jing , CN
ZHANG, Tong , CN
LI, Kang , CN
LUO, Lusong , CN
WEI, Min , CN
WANG, Zhiwei , CN
GUO, Yunhang , CN
|
| (73) |
Beigene Switzerland GmbH ,
Aeschengraben 27, 4051 Basel,
CH
|
| (54) | COMBINATION OF ZANUBRUTINIB WITH AN ANTI-CD20 OR AN ANTI-PD-1 ANTIBODY FOR USE IN TREATING CANCER |
| COMBINATION OF ZANUBRUTINIB WITH AN ANTI-CD20 OR AN ANTI-PD-1 ANTIBODY FOR USE IN TREATING CANCER |